LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

LLY

986.45

+0.17%↑

JNJ

242.9

+0.54%↑

ABBV

221.34

+0.76%↑

NVS

154.3

+0.79%↑

AZN

191.97

+0.98%↑

Search

ResMed Inc

Abrir

SetorSaúde

230.96

Visão Geral

Variação de preço das ações

24h

Atual

Mín

229.47

Máximo

234.55

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

24.993

61.417

Rendimento de Dividendos

0.89

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+28.31% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.89%

2.40%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

7 de mai. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-371M

37B

Abertura anterior

230.96

Fecho anterior

230.96

Sentimento de Notícias

By Acuity

50%

50%

133 / 351 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

15 de mar. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions -2-

15 de mar. de 2026, 21:14 UTC

Notícias Principais

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

16 de mar. de 2026, 00:00 UTC

Notícias Principais

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

15 de mar. de 2026, 23:45 UTC

Conversa de Mercado

Nikkei May Decline on Concerns About Prolonged Middle East Conflict -- Market Talk

15 de mar. de 2026, 23:44 UTC

Conversa de Mercado
Notícias Principais

Gold Falls as Rising Energy Prices Exacerbate Inflation Worries -- Market Talk

15 de mar. de 2026, 23:35 UTC

Conversa de Mercado
Notícias Principais

Oil Futures Rise on Supply Disruption Concerns -- Market Talk

15 de mar. de 2026, 23:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Micron Completes Acquisition Of PSMC's Tongluo P5 Site In Taiwan >MU

15 de mar. de 2026, 22:37 UTC

Conversa de Mercado

March Rate Hike Would Distance RBA From Government's May Budget -- Market Talk

15 de mar. de 2026, 22:18 UTC

Conversa de Mercado

RBA's Likely Hike Motivated By Inflation, Not Middle East -- Market Talk

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Adj Net $230.35M Vs. Adj Net $59.83M>1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech: 2025 Loss Due to High Base Effect, One-off Unrealized Gains Seen Last Year >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Rev $959.53M Vs. $594.49M >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech 2025 Loss $532.83M Vs. Net $2.96B >1548.HK

15 de mar. de 2026, 22:14 UTC

Ganhos

Genscript Biotech: 2025 Rev Supported by Substantial Increase in License Revenue>1548.HK

15 de mar. de 2026, 22:00 UTC

Notícias Principais

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 de mar. de 2026, 22:00 UTC

Notícias Principais

Oil Industry Warns Trump Administration Energy Crisis Will Likely Worsen -- WSJ

15 de mar. de 2026, 03:00 UTC

Notícias Principais

For Xi, Iran War Reinforces View of U.S. as Dangerous Superpower -- WSJ

14 de mar. de 2026, 15:00 UTC

Notícias Principais

Iran War Delivers Windfall to America's Oil Country -- WSJ

14 de mar. de 2026, 02:03 UTC

Ganhos

This Copper Stock Is Worth Mining for Profits -- Barrons.com

14 de mar. de 2026, 01:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Bill Ackman's Pershing Square IPO Is Back On -- Barrons.com

14 de mar. de 2026, 00:29 UTC

Aquisições, Fusões, Aquisições de Empresas

13D Filings -- Barrons.com

13 de mar. de 2026, 22:27 UTC

Conversa de Mercado
Notícias Principais

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 de mar. de 2026, 22:13 UTC

Conversa de Mercado
Notícias Principais

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 de mar. de 2026, 22:04 UTC

Conversa de Mercado
Notícias Principais

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 de mar. de 2026, 22:00 UTC

Aquisições, Fusões, Aquisições de Empresas

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Notícias Principais

Financial Services Roundup: Market Talk

13 de mar. de 2026, 20:02 UTC

Conversa de Mercado

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 de mar. de 2026, 19:50 UTC

Conversa de Mercado
Notícias Principais

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 de mar. de 2026, 19:35 UTC

Notícias Principais

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

28.31% parte superior

Previsão para 12 meses

Média 296.2 USD  28.31%

Máximo 345 USD

Mínimo 265 USD

Com base em 12 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

12 ratings

7

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

133 / 351 Ranking em Saúde

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat